It has been demonstrated that VSX1 functions as a potential oncogenic activator in ccRCC, with researchers analyzing the TCGA database to highlight its role in enhancing tumor aggressiveness in vitro. The gene discussed is VSX1; the disease is nonpapillary renal cell carcinoma.